A

Atkins, L. and Fallowfield, L. J. (2007) Fallowfield's Sexual Activity Questionnaire in women with without and at risk of cancer. Menopause International, 13 (3). pp. 103-9. ISSN 1754-0453

B

Bauer, Matthias, Jones, Alice Rhiannon, Khan, Raysa, Springett, Bradley, Dingler, Felix, Verduci, Lorena, Patel, Ketan, Fersht, Alan, Joerger, Andreas and Spencer, John (2019) A structure-guided molecular chaperone approach for restoring the transcriptional activity of the p53 cancer mutant Y220C. Future Medicinal Chemistry, 11 (19). pp. 2491-2504. ISSN 1756-8919

C

Cardoso, F., Bedard, P. L., Winer, E. P., Pagani, O., Senkus-Konefka, E., Fallowfield, L.J, Kyriakides, S., Costa, A., Cufer, T. and Albain, K. S. (2009) International guidelines for management of metastatic breast cancer: combination vs sequential single-agent chemotherapy. Journal of the National Cancer Institute, 101 (17). pp. 1174-81. ISSN 0027-8874

Cardoso, F., Fallowfield, L., Costa, A., Castiglione, M. and Senkus, E. (2011) Locally recurrent or metastatic breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology, 22 (supp 6). vi25-vi30. ISSN 0923-7534

F

Fallowfield, L J, Kilburn, L S, Langridge, C, Snowdon, C F, Bliss, J M and Coombes, R C (2012) Long-term assessment of quality of life in the Intergroup Exemestane Study: 5 years post-randomisation. British Journal of Cancer, 106 (6). pp. 1062-1067. ISSN 0007-0920

H

Harder, Helena, Ballinger, Rachel, Langridge, Carolyn, Ring, Alistair and Fallowfield, Lesley J (2013) Adjuvant chemotherapy in elderly women with breast cancer: patients' perspectives on information giving and decision making. Psycho-Oncology, 22 (12). pp. 2729-2735. ISSN 1057-9249

J

Jenkins, V, Catt, S, Banerjee, S, Gourley, C, Montes, A, Solis-Trapala, I, Monson, K and Fallowfield, L (2013) Patients' and oncologists' views on the treatment and care of advanced ovarian cancer in the UK: results from the ADVOCATE study. British Journal of Cancer, 108 (11). pp. 2264-2271. ISSN 0007-0920

Jenkins, V.A., Low, R. and Mitra, S. (2009) Hearing sensitivity in women following chemotherapy treatment for breast cancer: Results from a pilot study. Breast, 18 (5). pp. 279-283. ISSN 0960-9776

Jenkins, V.A., Shilling, V, Deutsch, G., Bloomfield, D., Morris, R., Allan, S., Bishop, H., Hodson, N., Mitra, S., Sadler, G., Shah, E., Stein, R., Whitehead, S. and Winstanley, J. (2006) A 3-year prospective study of the effects of adjuvant treatments on cognition in women with early stage breast cancer. British Journal of Cancer, 94 (6). pp. 828-34. ISSN 0007-0920

Jenkins, Valerie, Thwaites, Ryan, Cercignani, Mara, Sacre, Sandra, Harrison, Neil, Whiteley-Jones, Hefina, Mullen, Lisa, Chamberlain, Giselle, Davies, Kevin, Zammit, Charles, Matthews, Lucy and Harder, Helena (2016) A feasibility study exploring the role of pre-operative assessment when examining the mechanism of ‘chemo-brain’ in breast cancer patients. SpringerPlus, 5 (1). a390. ISSN 2193-1801

L

Leonard, R., Ballinger, R., Cameron, D., Ellis, P., Fallowfield, L.J., Gosney, M., Johnson, L., Kilburn, L. S., Makris, A., Mansi, J., Reed, M., Ring, A., Robinson, A., Simmonds, P., Thomas, G. and Bliss, J. M. (2011) Adjuvant chemotherapy in older women (ACTION) study - what did we learn from the pilot phase? British Journal of Cancer, 105 (9). pp. 1260-1266. ISSN 0007-0920

Lewis, Thomas, Corcoran, David B, Thurston, David E, Giles, Peter J, Ashelford, Kevin, Walsby, Elisabeth J, Fegan, Christopher D, Pepper, Andrea G S, Rahman, Khondaker Miraz and Pepper, Christopher (2020) Novel pyrrolobenzodiazepine benzofused hybrid molecules inhibit NF-κB activity and synergise with bortezomib and ibrutinib in hematological cancers. Haematologica. ISSN 0390-6078

P

Palmieri, C, Cleator, S, Kilburn, L S, Kim, S B, Ahn, S H, Beresford, M, Gong, G, Mansi, J, Mallon, E, Reed, S, Mousa, K, Fallowfield, L, Cheang, M, Morden, J, Page, K, Guttery, D S, Rghebi, B, Primrose, L, Shaw, J A, Thompson, A M, Bliss, J M and Coombes, R C (2014) NEOCENT: a randomised feasibility and translational study comparing neoadjuvant endocrine therapy with chemotherapy in ER-rich postmenopausal primary breast cancer. Breast Cancer Research and Treatment, 148 (3). pp. 581-590. ISSN 0167-6806

Patrick, D L, Cleeland, C S, von Moos, R, Fallowfield, L, Wei, R, Ohrling, K and Qian, Y (2014) Pain outcomes in patients with bone metastases from advanced cancer: assessment and management with bone-targeting agents. Supportive Care in Cancer, 23 (4). pp. 1157-68. ISSN 0941-4355

Pivot, Xavier, Jenkins, Valerie, Fallowfield, Lesley and The PrefHer Study Group, (2013) Preference for subcutaneous or intravenous administration of trastuzumab in patients with HER2-positive early breast cancer (PrefHer): an open-label randomised study. Lancet Oncology, 14 (10). pp. 962-70. ISSN 1470-2045

S

Shilling, Val and Jenkins, V.A. (2007) Self-reported cognitive problems in women receiving adjuvant therapy for breast cancer. European Journal of Oncology Nursing, 11 (1). pp. 6-15. ISSN 1462-3889

T

Tobias, J. S., Monson, K., Gupta, N., Macdougall, H., Glaholm, J., Hutchison, I., Kadalayil, L. and Hackshaw, A. (2010) Chemoradiotherapy for locally advanced head and neck cancer: 10-year follow-up of the UK Head and Neck (UKHAN1) trial. Lancet Oncology, 11 (1). pp. 66-74. ISSN 1474-5488 (Electronic)

V

von Moos, Roger, Body, Jean-Jacques, Egerdie, Blair, Stopeck, Alison, Brown, Janet E, Damyanov, Danail, Fallowfield, Lesley J, Marx, Gavin, Cleeland, Charles S, Patrick, Donald L, Palazzo, Felipe G, Qian, Yi, Braun, Ada and Chung, Karen (2013) Pain and health-related quality of life in patients with advanced solid tumours and bone metastases: integrated results from three randomized, double-blind studies of denosumab and zoledronic acid. Supportive Care in Cancer, 21 (12). pp. 3497-3507. ISSN 0941-4355